Page last updated: 2024-08-23

bromocriptine and methylnitronitrosoguanidine

bromocriptine has been researched along with methylnitronitrosoguanidine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, M; Iishi, H; Okuda, S; Taniguchi, H; Tatsuta, M1
Baba, M; Ichii, M; Iishi, H; Nakaizumi, A; Taniguchi, H; Tatsuta, M; Uehara, H1
Inoue, K; Maekawa, A; Nishikawa, A; Suzuki, T; Takahashi, M; Taya, K; Watanabe, G; Yoshida, M1

Other Studies

3 other study(ies) available for bromocriptine and methylnitronitrosoguanidine

ArticleYear
Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
    British journal of cancer, 1992, Volume: 65, Issue:3

    Topics: Adenocarcinoma; Animals; Bromocriptine; Dopamine; Epinephrine; Gastric Mucosa; Gastrins; Hydrogen-Ion Concentration; Male; Methylnitronitrosoguanidine; Neoplasms, Experimental; Norepinephrine; Rats; Rats, Inbred Strains; Stomach Neoplasms

1992
Attenuating effect of bromocriptine on cysteamine anticarcinogenesis of stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine.
    Cancer research, 1990, Sep-01, Volume: 50, Issue:17

    Topics: Animals; Bromocriptine; Cysteamine; Drug Interactions; Gastric Acid; Gastric Mucosa; Gastrins; Male; Methylnitronitrosoguanidine; Mitotic Index; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values; Stomach Neoplasms

1990
Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats.
    The Journal of reproduction and development, 2009, Volume: 55, Issue:2

    Topics: Adenocarcinoma; Animals; Bromocriptine; Carcinogens; Endometrial Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Histocytochemistry; Hormone Antagonists; Inhibins; Luteinizing Hormone; Methylnitronitrosoguanidine; Progesterone; Prolactin; Rats

2009